Clinical Trials on Biomechanical Parameters in Finland
Total 1 results
-
University of HelsinkiCompletedAndroid Obesity, Metabolic Parameters and Adipose Tissue (AT) Gene ExpressionFinland
Sponsors and Collaborators
- Forschungsverbund Rehabilitationswissenschaften Sachsen-Anhalt
- MITERA Children's Hospital
- Kolfarma s.r.l. - Italy
- Ramboll Group
- National University Polyclinics, Singapore
- Evolve BioSystems, Inc.
- University of Houston
- Siddhartha Ganguly
- The University of Texas System Healthcare Safety & Effectiveness Grants Program
- CirQuest Labs
- IRCCS-Istituto delle scienze neurologiche di Bologna
- Crovelis
- Penza State University
- Alfred Benzon Foundation
- BioSensics LLC
- No.2 People Hospital of Fuyang City
- Midlothian Care Center
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Universal Biosensors Pty Ltd
- Dr Jérôme Rambaud, MD, PhD; Sorbonne University, Paris, France
- View Full List
Medical Conditions
- FIGO Stage III Primary Peritoneal Cancer
- Periprosthetic Fracture of the Upper or Lower Limb
- Acute Myocardial Infraction or Chest Pain
- To Analyze the Frequency of Posttraumatic Stress Disorder in Cases With Awareness and Possible Awareness
- Spondylitis Secondary to Inflammatory Bowel Disease
- Focal Cortical Dysplasia
- Five-year Survival Rate
- Benign Lymphoproliferative Disorder
- Intramural Haematoma of Thoracic Aorta
- Maxillary Deficiency
- Lack of Drug Action
- Attention Deficit Hyperactivity Disorder Symptoms
- Disorder of Nipple
- Associated Conditions
- Severe Haemophilia A
- Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
- Germinal Center B-cell Type (GCB)
- Heart Failure With Reduced Ejection Fraction (HFrEF)
- Stimulant Use (Diagnosis)
- Tumor, Benign
- View Full List
Drug Interventions
- ECx1
- Total intravenous anesthesia with propofol
- Cisplatin
- Digoxin
- 0.2 mg/kg of oxycodone
- Ivacaftor
- Insulin degludec
- IV methylprednisolone
- I-131-CLR1404 Injection
- NBT-NM108
- EE 20 microgram with drospirenone 3 mg
- Palbociclib
- Insulin Glargine
- OSI-930 and erlotinib
- ZPL-3893787
- BAY1902607
- MT-1303-FormB
- Oseltamivir and chinese medicinal herbs
- RVX000222
- Etrumadenant
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Croatia
- Contract Research Organizations in Finland
- Contract Research Organizations in Gambia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Senegal
- Contract Research Organizations in South Africa
- Contract Research Organizations in Uruguay
- CRO list by country